• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PULMONX CORPORATION ZEPHYR ENDOBRONCHIAL VALVE (EBV)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PULMONX CORPORATION ZEPHYR ENDOBRONCHIAL VALVE (EBV) Back to Search Results
Model Number ZEPHYR 4.0-LP EBV
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Anemia (1706); Dyspnea (1816); Low Oxygen Saturation (2477)
Event Date 12/30/2021
Event Type  Death  
Manufacturer Narrative
Pulmonx has reached out to the physician and will submit a follow-up once the physician's narrative has been received.
 
Event Description
The patient was undergoing 2-stage zephyr valve treatment and had their valve placement procedure #2 on (b)(6) 2021.The patient experienced a copd exacerbation and was hospitalized on (b)(6) 2021 for hemolytic anemia and dyspnea increase.The patient was treated with tazocolline and ciflox.On (b)(6) 2022, the patient was desaturating.The desaturation was initially well controlled with oxygen; however the patient later experienced desaturation and unconsciousness and passed away on (b)(6) 2022.
 
Event Description
The patient was undergoing 2-stage zephyr valve treatment and had their valve placement procedure #2 on (b)(6) 2021.The patient experienced a copd exacerbation and was hospitalized on (b)(6) 2021 for hemolytic anemia and dyspnea increase.The patient was treated with tazocolline and ciflox.On (b)(6) 2022, the patient was desaturating.The desaturation was initially well controlled with oxygen; however the patient later experienced desaturation and unconsciousness and passed away on (b)(6) 2022.From the physician: "both the copd exacerbation and hemolytic anemia were thought to have led to this subjects death, although cardiogenic participation in this subject who was also suffering valvular and ischemic cardiopathy cannot be eliminated.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZEPHYR ENDOBRONCHIAL VALVE (EBV)
Type of Device
ENDOBRONCHIAL VALVE
Manufacturer (Section D)
PULMONX CORPORATION
700 chesapeake drive
redwood city CA 94063
Manufacturer Contact
mahtab fatemi
700 chesapeake drive
redwood city, CA 94063
6504072823
MDR Report Key13671271
MDR Text Key286638082
Report Number3007797756-2022-00051
Device Sequence Number1
Product Code NJK
UDI-Device Identifier00811907030218
UDI-Public(01)00811907030218(10)505144V71(17)220813
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,User Facility,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 05/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/04/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/13/2022
Device Model NumberZEPHYR 4.0-LP EBV
Device Catalogue NumberEBV-TS-4.0-LP
Device Lot Number505144-V7.1
Was Device Available for Evaluation? No
Date Manufacturer Received02/07/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/13/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention; Hospitalization;
Patient Age68 YR
Patient SexMale
-
-